Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
NCT ID: NCT02640742
Last Updated: 2017-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1232 participants
OBSERVATIONAL
2015-12-18
2016-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thus, we planned this study to evaluate the asthma control status, asthma symptoms (severity, frequency, and limitations on activities, etc.), Quality of line (QOL), and use of drugs for asthma attack in the study population in a real life setting by recruiting patients through medical institutions providing continued care for asthma patients.
Objectives of this Non-Interventional Study
1. Primary objective
To assess the proportion of adult asthma patients receiving continued treatment from physician in Japan in each asthma control status defined by JGL 2015 ("poorly-controlled," "insufficiently-controlled," and "well-controlled").
2. Secondary objectives
To evaluate asthma symptoms (intensity, frequency, and limitations on activities, etc.), QOL, use of drugs for asthma attack, and emotional feelings in the study population; and to investigate the effects of demographic characteristics and pathologic properties of each patient on the status of asthma control, asthma symptoms, QOL, use of drugs for asthma attack, and emotional feelings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 20 years or older at the time of providing the consent
* Receiving treatment for asthma as an outpatient at the time of providing the consent
* Physician definitive diagnosis of asthma at least 1 year before providing the consent
* Started to receive treatment with at least 1 of the following asthma drugs at least 1 year before providing the consent
Exclusion Criteria
* Assessed by the Investigator to require additional treatment due to worsening of asthma symptoms at the time of providing the consentEnrolled in this study in the past
* Scheduled to be hospitalized within 2 weeks after providing the consent due to asthma or any other disease
* Participating in another interventional study such as a clinical study at the time of providing the consent
* Considered by the Investigator as not appropriate for enrollment in this study due to inability to adhere to the procedures, limitations, and requirements of this study including answering and returning the questionnaires, etc.
20 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mitsuru Adachi, MD, PhD, Professor
Role: PRINCIPAL_INVESTIGATOR
International University of Health and Welfare
Gen Tamura, MD, PhD, President
Role: PRINCIPAL_INVESTIGATOR
Airway Institute in Sendai Co., Ltd
Masanori Nishikawa, DM, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Respiratory Medicine, Fujisawa City Hospital
Soichiro Hozawa, MD
Role: PRINCIPAL_INVESTIGATOR
Hiroshima Allergy and Respiratory Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hiramatsu Clinic, Specializing in Internal Medicine, Respiratory Internal Medicine, Asthma, Sleep and Total Care of Rehabilitation in Respiratory in Komaki
Komaki, Aichi-ken, Japan
Toyota Memorial Hospital
Toyota, Aichi-ken, Japan
Ken Respiratory & Allergy Clinic
Hachinohe, Aomori, Japan
Fukuokaken Saiseikai Futsukaichi Hospital
Chikushino-shi, Fukuoka, Japan
Japan Community Health Care Organization Kurume General Hospital
Kurume, Fukuoka, Japan
Kumashiro Hospital
Kurume, Fukuoka, Japan
Ikedo Cardiovascular Medicine Clinic
Kurume, Fukuoka, Japan
Omuta Tenryo Hospital
Omuta, Fukuoka, Japan
Omuta Hospital
Omuta, Fukuoka, Japan
Takagi Hospital
Ōkawa, Fukuoka, Japan
Nagata Hospital
Yanagawa, Fukuoka, Japan
Fujita General Hospital
Date-gun, Fukushima, Japan
Tohno Chuo Clinic
Mizunami, Gifu, Japan
Tsuchiya Clinic
Takasaki, Gunma, Japan
Idaimae Minami Yojo Naika Clinic
Sapporo, Hokkaido, Japan
Nakatani Hospital
Himeji, Hyōgo, Japan
Kobe City Medical Center General Hospital
Kobe, Hyōgo, Japan
Kobe City Hospital Organization Kobe City Medical Center West Hospital
Kobe, Hyōgo, Japan
Sudo Clinic
Morioka, Iwate, Japan
Sakaide City Hospital
Sakaidechō, Kagawa-ken, Japan
Takamatsu Hospital
Takamatsu, Kagawa-ken, Japan
Kamei Internal Medicine & Respiratory Clinic
Takamatsu, Kagawa-ken, Japan
Fujisawa City Hospital
Fujisawa, Kanagawa, Japan
Yokohama City Minato Red Cross Hospital
Yokohama, Kanagawa, Japan
Furuie Clinic
Yokohama, Kanagawa, Japan
Saiseikai Yokohama Southern Hospital
Yokohama, Kanagawa, Japan
Kanagawa Cardiovascular and Respiratory Center
Yokohama, Kanagawa, Japan
National Hospital Organization Fukuoka-Higashi Medical Center
Fukuoka, Koga, Japan
Sendai Medical Center
Sendai, Miyagi, Japan
National Hospital Organization Minami-Okayama Medical Center
Tsukubo-gun, Okayama-ken, Japan
Kawaguchi Respiratory Medicine Clinic
Higashiosaka, Osaka, Japan
Ikeda City Hospital
Ikeda, Osaka, Japan
Matsushita Memorial Hospital
Moriguchi, Osaka, Japan
Takatsuki Red Cross Hospital
Takatsuki, Osaka, Japan
Takatsuki General Hospital
Takatsuki, Osaka, Japan
Hamamatsu Medical Center
Hamamatsu, Shizuoka, Japan
Iwata City Hospital
Iwata, Shizuoka, Japan
Nihonbashi Medical & Allergy Clinic
Cyuo-ku, Tokyo, Japan
Futaba-cho Clinic
Itabashi-ku, Tokyo, Japan
National Hospital Organization Tokyo National Hospital
Kiyose, Tokyo, Japan
Yamazaki Chest Clinic
Koganei, Tokyo, Japan
Jinyu Clinic Hospital
Nakano-ku, Tokyo, Japan
Senzoku Kokyuuki & Allergy Clinic
Ōta-ku, Tokyo, Japan
National Center for Global Health and Medicine
Shinjyuku-ku, Tokyo, Japan
The Fraternity Memorial Hospital
Sumida-ku, Tokyo, Japan
Yuizen Clinic
Tachikawa, Tokyo, Japan
Hamanomachi Hospital
Fukuoka, , Japan
Fukuoka Sanno Hospital
Fukuoka, , Japan
Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers
Fukuoka, , Japan
Ohara General Hospital
Fukushima, , Japan
Sakurai Clinic
Hiroshima, , Japan
Hiroshima Allergic & Respiratory Clinic
Hiroshima, , Japan
Tsuya Internal Medicine & Respiratory Department Clinic
Hiroshima, , Japan
Yodogawa Christian Hospital
Osaka, , Japan
Saga-ken Medical Centre Koseikan
Saga, , Japan
Saitama Red Cross Hospital
Saitama, , Japan
Shizuoka General Hospital
Shizuoka, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D2287R00101
Identifier Type: -
Identifier Source: org_study_id